[go: up one dir, main page]

CN108117510A - A kind of preparation method of piperidine derivative - Google Patents

A kind of preparation method of piperidine derivative Download PDF

Info

Publication number
CN108117510A
CN108117510A CN201611074598.4A CN201611074598A CN108117510A CN 108117510 A CN108117510 A CN 108117510A CN 201611074598 A CN201611074598 A CN 201611074598A CN 108117510 A CN108117510 A CN 108117510A
Authority
CN
China
Prior art keywords
prepare compound
reaction prepare
reaction
solvent
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201611074598.4A
Other languages
Chinese (zh)
Inventor
许慧
邓泽平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan Huateng Pharmaceutical Co Ltd
Original Assignee
Hunan Huateng Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunan Huateng Pharmaceutical Co Ltd filed Critical Hunan Huateng Pharmaceutical Co Ltd
Priority to CN201611074598.4A priority Critical patent/CN108117510A/en
Publication of CN108117510A publication Critical patent/CN108117510A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

The invention discloses a kind of preparation methods of piperidine derivative 4 ((2 (amino methyl) 5 methylphenoxy) methyl) piperidinyl-1 t-butyl formate, using 2 hydroxyl, 4 tolyl aldehyde as starting material, target product is obtained by oximate, elimination, etherificate, catalytic hydrogenation reaction, which is important medicine intermediate.

Description

A kind of preparation method of piperidine derivative
Technical field
The present invention relates to a kind of novel processing step of medicine intermediate, more particularly to a kind of piperidine derivative 4- ((2- (amino methyl) -5- methylphenoxies) methyl) piperidines -1- t-butyl formates preparation method.
Technical background
Piperidine derivative 4- ((2- (amino methyl) -5- methylphenoxies) methyl) piperidines -1- t-butyl formates, structural formula For:
This compound 4- ((2- (amino methyl) -5- methylphenoxies) methyl) piperidines -1- t-butyl formates and relevant Derivative has extensive use in pharmaceutical chemistry and organic synthesis.4- ((2- (amino methyl) -5- methylphenoxies) first at present Base) piperidines -1- t-butyl formates synthesis it is more difficult.Easy to operate therefore, it is necessary to develop a raw material to be easy to get, reaction is easy In control, the suitable synthetic method of overall yield.
The content of the invention
The invention discloses a kind of piperidine derivative 4- ((2- (amino methyl) -5- methylphenoxies) methyl) piperidines -1- The preparation method of t-butyl formate, using 2- hydroxy-4-methyls benzaldehyde as starting material, by oximate, elimination, etherificate, catalysis Hydrogenation reaction obtains target product 5, and synthesis step is as follows:
(1) using 2- hydroxy-4-methyls benzaldehyde as starting material, 2 are obtained by oximation reaction;
(2) elimination reaction is carried out 2, obtains 3;
(3) 3 progress etherification reactions are obtained 4;
(4) 4 progress catalytic hydrogenation reactions are obtained 5;
In a preferred embodiment, the reagent used in the oximation reaction prepare compound 2 is selected from hydroxylamine hydrochloride; Reagent used in the elimination reaction prepare compound 3 is selected from acetic anhydride;Used in the etherification reaction prepare compound 4 Reagent is selected from 4- (hydroxymethyl) piperidines -1- t-butyl formates;Catalysis used in the catalytic hydrogenation reaction prepare compound 5 Agent is selected from palladium carbon.
In a preferred embodiment, the solvent used in the oximation reaction prepare compound 2 is selected from ethyl alcohol;It is described Elimination reaction prepare compound 3 used in solvent be selected from acetic anhydride;Solvent used in the etherification reaction prepare compound 4 Selected from tetrahydrofuran;Solvent used in the catalytic hydrogenation reaction prepare compound 5 is selected from methanol.
In a preferred embodiment, the reaction temperature used in the oximation reaction prepare compound 2 is room temperature;Institute The temperature used in elimination reaction prepare compound 3 stated is the reflux temperature of solvent;4 institute of etherification reaction prepare compound Temperature is room temperature;Temperature used in the catalytic hydrogenation reaction prepare compound 5 is room temperature.
The present invention relates to a kind of piperidine derivative 4- ((2- (amino methyl) -5- methylphenoxies) methyl) piperidines -1- first The preparation method of the preparation method of tert-butyl acrylate is reported currently without other Patents documents.
The present invention is further described by the following embodiment, these descriptions are not present invention to be made into one The restriction of step.It should be understood by those skilled in the art that the equivalent substitution made of technical characteristic to the present invention or changing accordingly Into still falling within protection scope of the present invention.
Specific embodiment mode
Embodiment 1
(1) synthesis of 2- hydroxy-4-methyls benzaldoxime
30g 2- hydroxy-4-methyl benzaldehydes are added in 270ml ethyl alcohol, 17g hydroxylamine hydrochlorides is added dropwise to, is stirred at room temperature Overnight, cooling adds in water and ethyl acetate, extracts liquid separation, collects organic phase, dry, and concentration obtains 23g 2- hydroxyl -4- first Benzaldehyde oxime.
(2) synthesis of 2- hydroxy-4-methyls benzonitrile
23g 2- hydroxy-4-methyl benzaldoximes are added in 190ml acetic anhydride, be heated to reflux stirring 2 it is small when, it is dense Contracting, residue is poured into ice water, is added in ethyl acetate extraction liquid separation, is collected organic phase, and dry, concentration is crossed post separation and obtained 16g 2- hydroxy-4-methyl benzonitriles.
(3) synthesis of 4- ((2- cyano -5- methylphenoxies) methyl) piperidines -1- t-butyl formates
15g 2- hydroxy-4-methyl benzonitriles are added in 180ml tetrahydrofurans, sequentially add 19g 4- (hydroxyl first Base) piperidines -1- t-butyl formates, 42g triphenylphosphines, 35g diisopropyl azodiformates, be stirred at room temperature 24 it is small when, concentrate, remain Silica gel post separation obtains 17g 4- ((2- cyano -5- methylphenoxies) methyl) piperidines -1- t-butyl formates on excess.
(4) synthesis of 4- ((2- (amino methyl) -5- methylphenoxies) methyl) piperidines -1- t-butyl formates
17g 4- ((2- cyano -5- methylphenoxies) methyl) piperidines -1- t-butyl formates are added to 170ml methanol In, add in 10% palladium carbons of 1g, lead to hydrogen, be stirred at room temperature 24 it is small when, filtering, collect filtrate, concentration, obtain 7g 4- ((2- (ammonia Ylmethyl) -5- methylphenoxies) methyl) piperidines -1- t-butyl formates.

Claims (6)

1. a kind of system of piperidine derivative 4- ((2- (amino methyl) -5- methylphenoxies) methyl) piperidines -1- t-butyl formates Using 2- hydroxy-4-methyls benzaldehyde as starting material, mesh is obtained by oximate, elimination, etherificate, catalytic hydrogenation reaction for Preparation Method Product 5 is marked, synthetic route is as follows,
2. the method according to claim 1, it is characterized in that the 4 steps reaction is,
(1) using 2- hydroxy-4-methyls benzaldehyde as starting material, 2 are obtained by oximation reaction;
(2) elimination reaction is carried out 2, obtains 3;
(3) 3 progress etherification reactions are obtained 4;
(4) 4 progress catalytic hydrogenation reactions are obtained 5;
3. the method according to claim 1, which is characterized in that the reagent used in the oximation reaction prepare compound 2 is selected from Hydroxylamine hydrochloride;Reagent used in the elimination reaction prepare compound 3 is selected from one or both of acetic anhydride, phosphorus oxychloride Mixture;Reagent used in the etherification reaction prepare compound 4 is selected from the tertiary fourth of 4- (hydroxymethyl) piperidines -1- formic acid Ester;The one kind of catalyst in palladium carbon, palladium dydroxide, Raney's nickel used in the catalytic hydrogenation reaction prepare compound 5 Or the mixture of one or more of several mixture.
4. the method according to claim 1, which is characterized in that the solvent used in the oximation reaction prepare compound 2 is selected from Methanol, ethyl alcohol, normal propyl alcohol, isopropanol, tetrahydrofuran, dichloromethane, toluene, ortho-xylene, paraxylene, meta-xylene, N, The mixture of one or more of dinethylformamide, DMAC N,N' dimethyl acetamide, triethylamine, pyridine, acetonitrile, acetic acid; Solvent used in the elimination reaction prepare compound 3 is selected from methanol, ethyl alcohol, normal propyl alcohol, isopropanol, acetic anhydride, trichlorine oxygen Phosphorus, tetrahydrofuran, dichloromethane, toluene, ortho-xylene, paraxylene, meta-xylene, N,N-dimethylformamide, N, N- bis- The mixture of one or more of methylacetamide, acetonitrile, water;Solvent used in the etherification reaction prepare compound 4 Selected from methanol, ethyl alcohol, normal propyl alcohol, isopropanol, tetrahydrofuran, dioxane, dichloromethane, chloroform, toluene, adjacent diformazan One kind in benzene, paraxylene, meta-xylene, N,N-dimethylformamide, DMAC N,N' dimethyl acetamide, acetonitrile, phosphorus oxychloride Or several mixture;Solvent used in the catalytic hydrogenation reaction prepare compound 5 is selected from methanol, ethyl alcohol, normal propyl alcohol, different Propyl alcohol, tetrahydrofuran, dioxane, dichloromethane, chloroform, toluene, ortho-xylene, paraxylene, meta-xylene, N, N- The mixture of one or more of dimethylformamide, DMAC N,N' dimethyl acetamide, acetic acid, water.
5. the method according to claim 1, which is characterized in that the reaction temperature used in the oximation reaction prepare compound 2 It is the reflux temperature of 0 DEG C~solvent;Temperature used in the elimination reaction prepare compound 3 is the reflux temperature of 0 DEG C~solvent Degree;Temperature used in the etherification reaction prepare compound 4 is the reflux temperature of 0 DEG C~solvent;The catalytic hydrogenation is anti- Answer the reflux temperature that the temperature used in prepare compound 5 is 0 DEG C~solvent.
6. the method according to claim 1, which is characterized in that the reaction temperature used in the oximation reaction prepare compound 2 It is room temperature;Temperature used in the elimination reaction prepare compound 3 is the reflux temperature of solvent;It is prepared by the etherification reaction Temperature used in compound 4 is room temperature;Temperature used in the catalytic hydrogenation reaction prepare compound 5 is room temperature.
CN201611074598.4A 2016-11-29 2016-11-29 A kind of preparation method of piperidine derivative Withdrawn CN108117510A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611074598.4A CN108117510A (en) 2016-11-29 2016-11-29 A kind of preparation method of piperidine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611074598.4A CN108117510A (en) 2016-11-29 2016-11-29 A kind of preparation method of piperidine derivative

Publications (1)

Publication Number Publication Date
CN108117510A true CN108117510A (en) 2018-06-05

Family

ID=62226805

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611074598.4A Withdrawn CN108117510A (en) 2016-11-29 2016-11-29 A kind of preparation method of piperidine derivative

Country Status (1)

Country Link
CN (1) CN108117510A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103930416A (en) * 2011-09-09 2014-07-16 默克专利股份公司 Benzonitrile derivatives as kinase inhibitors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103930416A (en) * 2011-09-09 2014-07-16 默克专利股份公司 Benzonitrile derivatives as kinase inhibitors

Similar Documents

Publication Publication Date Title
WO2010081404A1 (en) Method for preparing linezolid and intermediates thereof
CN110028462A (en) A method of preparing isoxazoles intermediate and isoxazoline
CN103391927A (en) Novel process for preparation of linezolid and its novel intermediates
EP3201171B1 (en) Method of preparing intermediate of salmeterol
CN108117510A (en) A kind of preparation method of piperidine derivative
Chen et al. Synthesis and Insecticidal Evaluation of Novel Phthalic Diamides Containing 1, 2, 3‐Triazoles via Click Reaction
CN106810513A (en) A kind of preparation method of bridged piperazine derivatives
CN108610309A (en) A kind of preparation method of piperidine derivative
CN107698491A (en) A kind of preparation method of substituted piperidine derivative
CN107778215A (en) A kind of preparation method of fluorine substituted piperidine derivative
CN107778216A (en) A kind of preparation method of fluorine substituted piperidine derivative
CN107286076A (en) A kind of preparation method of piperidines
CN107400082A (en) A kind of preparation method of substituted piperidine derivative
CN106854174A (en) A kind of preparation method of 4 substituted piperidine derivatives
CN108640861B (en) Alkynamide-mediated "one-pot" preparation of macrolides
CN109574866B (en) Preparation method of 2, 6-dimethylaniline long-chain compound
CN108069918B (en) One-pot method for preparing 3-difluoromethylisoxazole compounds
CN108299224A (en) A kind of preparation method of N- acetyl group -1- cyclohexylethylamines
CN113801062B (en) Preparation method of 3-amino-5- (3, 5-difluorobenzyl) -1H-indazole
CN109180407A (en) A method of nitrile is prepared by aldoxime
CN103755657A (en) Preparation method of rivaroxaban intermediate
CN108484516A (en) A kind of SC 69124 sodium impurity and preparation method thereof
CN100500650C (en) A kind of chemical synthesis method of nitrile substance
Mohareb et al. Synthesis of novel tryptophan derivatives of potential biological activity
WO2008124969A1 (en) Preparation method of rivastigmine and its intermediates

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20180605

WW01 Invention patent application withdrawn after publication